Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New drugs of 1999.

D A Hussar1

  • 1Philadelphia College of Pharmacy, University of the Sciences in Philadelphia, PA 19104-4495, USA. d.hussar@usip.edu

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)
|March 24, 2000
PubMed
Summary

In 1999, 28 new therapeutic agents offered significant advantages over existing medications. Pharmacists must understand these new drugs to effectively counsel patients and inform healthcare professionals.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New drugs of 2000.

Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)·2001
Same author

Mifepristone--controversy, beliefs, and politics--issues for everyone.

The Annals of pharmacotherapy·2001
Same author

New drugs 2001. Part I.

Nursing·2001
Same author

New drugs 2000. Part II.

Nursing·2000
Same author

New drugs 2000. Part I.

Nursing·2000
Same author

New drugs 99, Part IV.

Nursing·1999

Area of Science:

  • Pharmacology
  • Drug Development

Background:

  • New therapeutic agents are continuously introduced into the market.
  • Understanding the properties of these agents is crucial for healthcare professionals.

Purpose of the Study:

  • To review the key properties of 28 new therapeutic agents marketed in 1999.
  • To compare these new agents with older medications for similar indications.

Main Methods:

  • Review of published studies.
  • Consultation of drug information reference sources.
  • Analysis of product labeling.

Main Results:

  • Detailed review of indications, dosage, and administration for each new agent.
  • Analysis of pharmacokinetic properties, adverse events, and drug interactions.
  • Discussion of practical considerations and comparison with older drugs.

Conclusions:

  • Several new agents marketed in 1999 present notable advantages over older drugs.
  • Pharmacist knowledge of these agents is vital for patient counseling and professional information dissemination.

Related Experiment Videos